SBSarah Bastkowski

Sarah Bastkowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah Bastkowski has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unsupervised decomposition of massively parallel TraDIS-Xpress fitness data from Escherichia coli identifies distinct functional and expression modules of antimicrobial resistance determinants

    by Muhammad Yasir, A. Keith Turner, Andrea Telatin, Sarah Bastkowski, Emma R. Holden, Ian G. Charles, Mark A. Webber

    Linking genotype to phenotype is a central goal in biology, one way to do this is using transposon insertion sequencing (TIS) where the fitness impacts of mutations across a genome are assessed in different conditions. Traditional analyses use comparison of each gene response independently in control versus test conditions, so a compendium of hundreds of test conditions returns hundreds of separate ranked gene lists. To unlock the potential information hidden within large data sets, we applied independent component (ICA) analysis to 754 Escherichia coli BW25113 TraDIS-Xpress samples. These samples included a series of antibiotic and other stress condition exposures. ICA is designed to identify hidden structure within complex data and to extract meaningfully linked components. In this analysis each annotated gene was resolved into a gene body and 198 bp 5′ and 3′ features so that expression effects driven by the transposon’s outwards facing promoter enter the matrix separately from gene disruption effects. The decomposition returned 99 components, which we term fxModules, which were defined as containing elements with similar responses across the whole compendium rather than per any individual experiment. Of the 754 stress samples, the antibiotic arm included 110 samples derived from exposure to 14 separate agents at multiple concentrations. Many of these have been highly studied allowing us to explore the accuracy of predicted responsive fxModules. This analysis showed excellent predictive power of the approach and the fxModules responsive to individual drugs typically reproduced known mechanisms at a resolution superior to analysis of single gene sets. For example, exposure to fosfomycin identified responsive fxModules containing genes which are known to be involved in uptake of the drug, cAMP-CRP control and exposure to gentamicin identified oxidative phosphorylation split across three fxModules responding with different magnitudes and directions at different concentrations. This recapitulates recent work studying the landscape of E. coli genes sensitive to this drug with high precision without any prior knowledge of functional annotation. Similarly precise predictions were made for other drugs. Responsive modules also identified novel groups of genes and linkages beyond the boundaries of defined pathways as being responsive to various stresses demonstrating the ability to predict new genotype-phenotype links. Inclusion of the regulatory regions also resolved fxModules which were entirely contributed by promoter regions, for example for chloramphenicol genes responsible for efflux were identified by signals in intergenic control regions, and unidirectional insertions in gene bodies, a signal that a gene level matrix would not be able to predict with accuracy. These data show that ICA decomposition provides an efficient and accurate annotation independent approach to identifying sets of genes with related functional impacts in any given condition in the compendium. The functional modular association of genes also help in predicting gene functions of unknown genes based on the group function. This approach allows rapid identification of novel genotype-phenotype links and unlocks the power of multiple comparisons of transposon mutagenesis data.

  • Open Access

    Mapping the genomic landscape of antibiotic susceptiblity in Escherichia coli

    by Sarah Bastkowski, A. Keith Turner, Muhammad Yasir, Caroline Jarvis, Ian Charles, Mark Webber

    Antibiotic treatment failure is frequently driven by bacterial insusceptibility, yet understanding of the full repertoire of genes contributing to this in Gram-negative bacteria remains incomplete. We used TraDIS-Xpress, a high-density transposon mutagenesis approach, to systematically define the genetic and physiological determinants of Escherichia coli K-12 susceptibility to 13 antibiotics spanning all major drug classes and multiple concentrations. Beyond known resistance determinants, our data reveal that the E. coli core genome plays a central role in modulating susceptibility. Disruption of metabolic, energy-generating, growth-associated, and amino acid biosynthetic pathways commonly enhanced survival under antibiotic stress, indicating that reduced metabolic activity and growth modulation broadly promote survival during exposure to bactericidal drugs. In contrast, pathways involved in DNA replication, peptidoglycan and lipopolysaccharide synthesis, aminoacyl-tRNA biosynthesis, riboflavin metabolism, and terpenoid backbone biosynthesis consistently aided survival. Experimental validation using defined mutants confirmed that disruption of selected metabolic and respiratory pathways confers survival benefits across multiple antibiotic classes. Together, this work provides a genome-scale framework for understanding antibiotic susceptibility in E. coli , identifies conserved physiological pathways underpinning survival, and offers new opportunities for strategies aimed at reversing insusceptibility and improving antibiotic efficacy.


  • Open Access

    Identification of genes important for response of Pseudomonas aeruginosa biofilms to ciprofloxacin exposure

    by Meng Wang, Emma R Holden, Muhammad R Yasir, Sarah Bastkowski, Keith Turner, Leanne P Sims, Matthew W Gilmour, Ian G W Charles, Mark A Webber

    Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections in immunocompromised individuals, such as patients with cystic fibrosis where it commonly forms biofilms. Ciprofloxacin is used extensively to treat P. aeruginosa infections, but its effectiveness can be significantly reduced due to biofilm formation. Although many individual genes associated with biofilm formation or ciprofloxacin resistance have been characterised, the genetic basis of P. aeruginosa biofilm fitness related to antibiotic challenge remains incompletely understood. In this study we employed a whole genome screen to assay the impact of gene disruptions or altered gene expression on survival of P. aeruginosa biofilms exposed to different concentrations of ciprofloxacin. Genes impacting fitness in the biofilm context were identified by comparing the biofilm samples to planktonic samples harvested at 12h, 24h and 48h with and without ciprofloxacin. Genes associated with c-di-GMP regulation and Gac/Rsm signalling were identified as primary regulators for biofilm formation in the presence and absence of ciprofloxacin. In addition, a group of genes involved in respiration, metabolism (especially polyamine metabolism), and various transporter and efflux systems were identified as important for biofilm fitness. Ciprofloxacin specifically imposed a selective pressure on flagellar function and Psl production which were essential for survival in early biofilms. Moreover, transposon insertions within the CPA gene clusters (PA5448-PA5451 and PA5455-PA5456) and the salvage peptidoglycan recycling pathway showed reduced fitness in late biofilms at high concentration of ciprofloxacin, indicating that cell envelope integrity is beneficial for mature biofilms. This study identifies important determinants of survival for biofilms at different stages of maturity in the presence and absence of ciprofloxacin and implicates potential therapeutic targets for antibiofilm drug development.

  • Open Access

    Genome-Wide Analysis of Innate Susceptibility Mechanisms of Escherichia coli to Colistin

    by Muhammad Yasir, A. Keith Turner, Sarah Bastkowski, Martin Lott, Emma R. Holden, Andrea Telatin, Andrew J. Page, Mark A. Webber, Ian G. Charles

    Colistin is an antibiotic that has seen increasing clinical use for the treatment of human infections caused by Gram-negative pathogens, particularly due to the emergence of multidrug-resistant pathogens. Colistin resistance is also a growing problem and typically results from alterations to lipopolysaccharides mediated by phosphoethanolamine (pETn) transferase enzymes which can be encoded on the chromosome, or plasmids. In this study, we used ‘TraDIS-Xpress’ (Transposon Directed Insertion site Sequencing with expression), where a high-density transposon mutant library including outward facing promoters in Escherichia coli BW25113 identified genes involved in colistin susceptibility. We examined the genome-wide response of E. coli following exposure to a range of concentrations of colistin. Our TraDIS-Xpress screen confirmed the importance of overexpression of the two-component system basSR (which regulates pETn transferases) but also identified a wider range of genes important for survival in the presence of colistin, including genes encoding membrane associated proteins, DNA repair machinery, various transporters, RNA helicases, general stress response genes, fimbriae and phosphonate metabolism. Validation experiments supported a role in colistin susceptibility for novel candidate genes tested. TraDIS-Xpress is a powerful tool that expands our understanding of the wider landscape of genes involved in response to colistin susceptibility mechanisms.


  • Open Access

    LoRTIS Software Suite: Transposon mutant analysis using long-read sequencing

    by Martin Lott, Muhammad Yasir, A. Keith Turner, Sarah Bastkowski, Andrew Page, Mark A. Webber, Ian G. Charles

    To date transposon insertion sequencing (TIS) methodologies have used short-read nucleotide sequencing technology. However, short-read sequences are unlikely to be matched correctly within repeated genomic regions which are longer than the sequence read. This drawback may be overcome using long-read sequencing technology. We have developed a suite of new analysis tools, the “LoRTIS software suite” (LoRTIS-SS), that produce transposon insertion site mapping data for a reference genome using long-read nucleotide sequence data. Long-read nucleotide sequence data can be applied to TIS, this enables the unique mapping of transposon insertion sites within long genomic repeated sequences. Here we present long-read TIS analysis software, LoRTIS-SS, which uses the Snakemake framework to manage the workflow. A docker image is provided, complete with dependencies and ten scripts are included for experiment specific data processing before or after use of the main workflow. The workflow uses long-read nucleotide sequence data such as those generated by the MinION sequencer (Oxford Nanopore Technologies). The unique mapping properties of long-read sequence data were exemplified by reference to the ribosomal RNA genes of Escherichia coli strain BW25113, of which there are 7 copies of ∼4.9 kbases in length that are at least 99% similar. Of reads that matched within rRNA genes, approximately half matched uniquely. The software workflow outputs data compatible with the established Bio-TraDIS analysis toolkit allowing for existing workflows to be easily upgraded to support long-read sequencing.


  • Open Access

    Chemical biology-whole genome engineering datasets predict new antibacterial combinations

    by Arthur K. Turner, Muhammad Yasir, Sarah Bastkowski, Andrea Telatin, Andrew Page, Mark Webber, Ian Charles

    Trimethoprim and sulfamethoxazole are used commonly together as cotrimoxazole for the treatment of urinary tract and other infections. The evolution of resistance to these and other antibacterials threatens therapeutic options for clinicians. We generated and analysed a chemical-biology-whole-genome data set to predict new targets for antibacterial combinations with trimethoprim and sulfamethoxazole. For this we used a large transposon mutant library in Escherichia coli BW25113 where an outward-transcribing inducible promoter was engineered into one end of the transposon. This approach allows regulated expression of adjacent genes in addition to gene inactivation at transposon insertion sites, a methodology that has been called TraDIS-Xpress. These chemical genomic data sets identified mechanisms for both reduced and increased susceptibility to trimethoprim and sulfamethoxazole. The data identified that over-expression of FolA reduced trimethoprim susceptibility, a known mechanism for reduced susceptibility. In addition, transposon insertions into the genes tdk, deoR, ybbC, hha, ldcA, wbbK and waaS increased susceptibility to trimethoprim and likewise for rsmH, fadR, ddlB, nlpI and prc with sulfamethoxazole, while insertions in ispD, uspC, minC, minD, yebK, truD and umpG increased susceptibility to both these antibiotics. Two of these genes’ products, Tdk and IspD, are inhibited by AZT and fosmidomycin respectively, antibiotics that are known to synergise with trimethoprim. Thus, the data identified two known targets and several new target candidates for the development of co-drugs that synergise with trimethoprim, sulfamethoxazole or cotrimoxazole. We demonstrate that the TraDIS-Xpress technology can be used to generate information-rich chemical-genomic data sets that can be used for antibacterial development.


  • Open Access

    AlbaTraDIS: Comparative analysis of large datasets from parallel transposon mutagenesis experiments

    by Andrew J. Page, Sarah Bastkowski, Muhammad Yasir, A. Keith Turner, Thanh Le Viet, George M. Savva, Mark A. Webber, Ian G. Charles

    Bacteria need to survive in a wide range of environments. Currently, there is an incomplete understanding of the genetic basis for mechanisms underpinning survival in stressful conditions, such as the presence of anti-microbials. Transposon directed insertion-site sequencing (TraDIS) is a powerful tool to identify genes and networks which are involved in survival and fitness under a given condition by simultaneously assaying the fitness of millions of mutants, thereby relating genotype to phenotype and contributing to an understanding of bacterial cell biology. A recent refinement of this approach allows the roles of essential genes in conditional stress survival to be inferred by altering their expression. These advancements combined with the rapidly falling costs of sequencing now allows comparisons between multiple experiments to identify commonalities in stress responses to different conditions. This capacity however poses a new challenge for analysis of multiple data sets in conjunction. To address this analysis need, we have developed ‘AlbaTraDIS’; a software application for rapid large-scale comparative analysis of TraDIS experiments that predicts the impact of transposon insertions on nearby genes. AlbaTraDIS can identify genes which are up or down regulated, or inactivated, between multiple conditions, producing a filtered list of genes for further experimental validation as well as several accompanying data visualisations. We demonstrate the utility of our new approach by applying it to identify genes used by Escherichia coli to survive in a wide range of different concentrations of the biocide Triclosan. AlbaTraDIS identified all well characterised Triclosan resistance genes, including the primary target, fabI. A number of new loci were also implicated in Triclosan resistance and the predicted phenotypes for a selection of these were validated experimentally with results being consistent with predictions. AlbaTraDIS provides a simple and rapid method to analyse multiple transposon mutagenesis data sets allowing this technology to be used at large scale. To our knowledge this is the only tool currently available that can perform these tasks. AlbaTraDIS is written in Python 3 and is available under the open source licence GNU GPL 3 from https://github.com/quadram-institute-bioscience/albatradis.


  • Open Access

    TraDIS-Xpress: a high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance

    by Muhammad Yasir, A. Keith Turner, Sarah Bastkowski, David Baker, Andrew J. Page, Andrea Telatin, Minh-Duy Phan, Leigh Monahan, George M. Savva, Aaron Darling, et al.

    Understanding the genetic basis for a phenotype is a central goal in biological research. Much has been learnt about bacterial genomes by creating large mutant libraries and looking for conditionally important genes. However, current genome-wide methods are largely unable to assay essential genes which are not amenable to disruption. To overcome this limitation, we developed a new version of “TraDIS” (transposon directed insertion-site sequencing) that we term “TraDIS-Xpress” that combines an inducible promoter into the transposon cassette. This allows controlled overexpression and repression of all genes owing to saturation of inserts adjacent to all open reading frames as well as conventional inactivation. We applied TraDIS-Xpress to identify responses to the biocide triclosan across a range of concentrations. Triclosan is endemic in modern life, but there is uncertainty about its mode of action with a concentration-dependent switch from bacteriostatic to bactericidal action unexplained. Our results show a concentration-dependent response to triclosan with different genes important in survival between static and cidal exposures. These genes include those previously reported to have a role in triclosan resistance as well as a new set of genes, including essential genes. Novel genes identified as being sensitive to triclosan exposure include those involved in barrier function, small molecule uptake, and integrity of transcription and translation. We anticipate the approach we show here, by allowing comparisons across multiple experimental conditions of TraDIS data, and including essential genes, will be a starting point for future work examining how different drug conditions impact bacterial survival mechanisms.


  • Open Access

    A genome wide analysis ofEscherichia coliresponses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate and phosphate transport systems

    by Muhammad Yasir, Keith Turner, Sarah Bastkowski, Ian G Charles, Mark A. Webber

    Fosfomycin is an antibiotic which has seen a revival in use due to its unique mechanism of action and resulting efficacy against isolates resistant to many other antibiotics. Mechanisms of resistance have been elucidated and loss of function mutations within the genes encoding the sugar importers, GlpT and UhpT are commonly selected for by fosfomycin exposure inE. coli. There has however not been a genome wide analysis of the basis for fosfomycin sensitivity reported to date. Here we used ‘TraDIS-Xpress’ a high-density transposon mutagenesis approach to assay the role of all genes inE. coliin fosfomycin sensitivity. The data confirmed known mechanisms of action and resistance as well as identifying a set of novel loci involved in fosfomycin sensitivity. The assay was able to identify sub domains within genes of importance and also revealed essential genes with roles in fosfomycin sensitivity based on expression changes. Novel genes identified included those involved in glucose metabolism, the phosphonate import and breakdown system,phnC-Mand the phosphate importer,pstSACB. The impact of these genes in fosfomycin sensitivity was validated by measuring the susceptibility of defined inactivation mutants. This work reveals a wider set of genes contribute to fosfomycin sensitivity including core sugar metabolism genes and two transport systems previously unrecognised as having a role in fosfomycin sensitivity. The work also suggests new routes by which drugs with a phosphonate moiety may be transported across the inner membrane of Gram-negative bacteria.Importance: The emergence and spread of antibiotic resistant bacteria had resulted in increased use of alternative drugs which retain efficacy against isolates resistant to other classes of drugs. One example is fosfomycin; an old drug which has found greatly increased use in recent years. We studied the mechanisms of fosfomycin resistance by applying a genome wide screen based on comparing the fitness of a massive library of transposon mutants in the presence of fosfomycin. This approach identified the previously known mechanisms of resistance but also identified a number of new pathways which contribute to fosfomycin sensitivity including two importer systems. This information advances our knowledge about an increasingly important antibiotic and identifies new potential routes to resistance.

  • Open Access

    A new massively-parallel transposon mutagenesis approach comparing multiple datasets identifies novel mechanisms of action and resistance to triclosan

    by Muhammad Yasir, A. Keith Turner, Sarah Bastkowski, Andrew J. Page, Andrea Telatin, Minh-Duy Phan, Leigh G. Monahan, Aaron E. Darling, Mark A. Webber, Ian G. Charles

    The mechanisms by which antimicrobials exert inhibitory effects against bacterial cells and by which bacteria display resistance vary under different conditions. Our understanding of the full complement of genes which can influence sensitivity to many antimicrobials is limited and often informed by experiments completed in a small set of exposure conditions. Capturing a broader suite of genes which contribute to survival under antimicrobial stress will improve our understanding of how antimicrobials work and how resistance can evolve. Here, we apply a new version of ‘TraDIS’ (Transposon Directed Insert Sequencing); a massively parallel transposon mutagenesis approach to identify different responses to the common biocide triclosan across a 125-fold range of concentrations. We have developed a new bioinformatic tool ‘AlbaTraDIS’ allowing both predictions of the impacts of individual transposon inserts on gene function to be made and comparisons across multiple TraDIS data sets. This new TraDIS approach allows essential genes as well as non-essential genes to be assayed for their contribution to bacterial survival and growth by modulating their expression. Our results demonstrate that different sets of genes are involved in survival following exposure to triclosan under a wide range of concentrations spanning bacteriostatic to bactericidal. The identified genes include those previously reported to have a role in triclosan resistance as well as a new set of genes not previously implicated in triclosan sensitivity. Amongst these novel genes are those involved in barrier function, small molecule uptake and integrity of transcription and translation. These data provide new insights into potential routes of triclosan entry and bactericidal mechanisms of action. Our data also helps to put recent work which has demonstrated the ubiquitous nature of triclosan in people and the built environment into context in terms of how different triclosan exposures may influence evolution of bacteria. We anticipate the approach we show here that allows comparisons across multiple experimental conditions of TraDIS data will be a starting point for future work examining how different drug conditions impact bacterial survival mechanisms.